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Deletion of the nef gene frommacaque simian immunodeficiency virus (SIVmac) attenuates its ability to cause
disease. Pathogenic viruses occasionally emerge in macaques infected with Nef-deleted SIVmac, with some
genetic determinants mapping to the envelope (env) gene. An intriguing new study shows that these changes
endow Env with a Nef-like ability to counteract tetherin/BST2 (Serra-Moreno et al., 2011).Tetherin (bone marrow stromal cell
antigen 2, BST2/CD317) is an interferon-
induced membrane protein that inhibits
the release of diverse mammalian envel-
oped virus particles by mediating their
retention on the surface of infected cells
(Evans et al., 2010). Tetherin dimers are
proposed to partition into assembling
virions and crosslink the nascent particle
to the plasma membrane. The acquisition
of countermeasures encoded by various
mammalian viruses that target its function
highlights the potential importance of
tetherin in innate antiviral immunity.
The ability to counteract tetherin is
conserved among primate immunodefi-
ciency viruses (Figure 1) (Sauter et al.,
2010). While HIV-1 employs its accessory
protein Vpu to target human tetherin,
many SIVs that do not encode a vpu
gene harbor an analogous activity in their
Nef protein. Nef, a multifunctional adaptor
protein that mediates the downregulation
of a host of cell surface immunoregulatory
proteins, is critical for SIVs to replicate
efficiently in vivo. Nef-deleted macaque
simian immunodeficiency virus (SIVmac
Dnef) strains are attenuated in macaques
but maintain a persistent low-level repli-
cation. Occasionally, however, SIVmacD
nef-infected macaques progress to
disease, and the reisolated virus is patho-
genic (Alexander et al., 2003). The genetic
changes associated with pathogenic SIV-
mac Dnef (DNefP) include amino acid
substitutions in the cytoplasmic tail of
the gp41 subunit of the Env glycoprotein.
Tetherin antagonism by SIV Nef re-
quires a G/DDIWK motif present in the
cytoplasmic tails of primate tetherins
(Sauter et al., 2010). This motif has been
deleted in humans, and thus human teth-
erin is resistant to SIV/HIV Nef proteins.
HIV-2, like SIVmac, is derived from the
sooty mangabey SIV (SIVsm) that doesnot encode a vpu gene. Remarkably, in
some laboratory isolates of HIV-2 and
one human CD4+ T cell-line passaged
tantalus SIV (SIVtan), the envelope glyco-
protein can antagonize human and
primate tetherins (Gupta et al., 2009;
Hauser et al., 2010; Le Tortorec and
Neil, 2009). Like Vpu, HIV-2 Env downre-
gulates surface tetherin levels and
induces its accumulation in intracellular
compartments, away from viral assembly
sites on the plasma membrane. Env inter-
acts with tetherin, determined by the
extracellular domains of both proteins.
However, this interaction is not sufficient;
tetherin antagonism by HIV-2 Env is
dependent both on proteolytic Env matu-
ration to its mature subunits (gp105 and
gp41) and a tyrosine-based sorting signal
(GYXXF) that binds the clathrin adaptor
AP2—and which is conserved in the cyto-
plasmic tails of HIV/SIV Envs. It is unclear
how widespread tetherin antagonism
is among primary HIV-2 isolates and
whether the development of tetherin
antagonism in Env was essential for the
virus to adapt to its new host after
cross-species transmission. Now, Serra-
Moreno and coworkers demonstrate that
in macaques there is evidence that teth-
erin can exert such a selective pressure
on the closely related SIVmac Env and
that this correlates with enhanced viral
replication and pathogenesis in vivo
(Serra-Moreno et al., 2011).
The genetic changes acquired by the
SIVmac DnefP isolate are sufficient to
confer the ability to antagonize rhesus
tetherin to the virus (Serra-Moreno et al.,
2011). Moreover, SIVmac Dnef replication
in macaque CD4+ T cells displays greater
sensitivity to type-1 interferon than wild-
type SIVmac, and the DNefP adaptions
reverse this. Since the nef gene is not
reconstituted in DNefP, the authors goCell Host & Microbeon to show that the resistance to rhesus
tetherin was attributable to five amino
acid changes in the cytoplasmic tail of
DNefP Env. DNefP Env had an enhanced
ability to interact with rhesus tetherin in
coimmunoprecipitations, and like HIV-2
Env, antagonism of tetherin required
the membrane-proximal GYXXF sorting
signal. DNefP Env colocalized with teth-
erin in intracellular compartments,
although surface downregulation in in-
fected cells was minor, perhaps suggest-
ing tetherin removal from the surface is
not strictly required.
There are some key differences
between DNefP Env-mediated tetherin
antagonism and that by HIV-2 Env,
implying that distinct adaptions in
different parts of the Env molecule result
in similar mechanisms. First, aside from
the membrane-proximal amino acids
that include the GYXXF motif, the gp41
cytoplasmic tail is dispensable for HIV-2;
here, it is the fundamental determinant
of tetherin antagonism by DNefP Env.
Remarkably, grafting the DNefP gp41 tail
onto a heterologous membrane protein
(CD4) endows the chimera with the
ability to bind tetherin and counteract
restriction. Second, unlike HIV-2 and
SIVtan Envs, which target human and
primate tetherins through a determinant
in their extracellular coiled-coil domains
(Gupta et al., 2009; Hauser et al., 2010;
Le Tortorec and Neil, 2009), DNefP Env
is specific for rhesus tetherin. While
DNefP Env does not require the G/DDIWK
patch in the cytoplasmic tail of tetherin
that is deleted in humans, it does depend
on other primate species-specific resi-
dues flanking the tetherin’s dual tyrosine
endocytic motif. Rhesus tetherin is poly-
morphic, and recent analysis of primate
tetherins suggests that the cytoplasmic
tail has been under heavy positive9, January 20, 2011 ª2011 Elsevier Inc. 3
Figure 1. Multiple Mechanisms for Targeting Tetherin in Primate Immunodeficiency Viruses
The ability to counteract tetherin-mediated restriction of viral particle release is conserved among primate immunodeficiency viruses. Tetherin dimers cycle
between the cell surface, trans-Golgi Network (TGN), and the endosomal network via clathrin adaptors AP1 and AP2. The majority of SIVs target their host
species’ tetherin through the accessory protein Nef, determined by a conserved G/DDIWK motif in primate tetherin cytoplasmic tails. This motif is absent in
human tetherin, and it is thus resistant to all SIV Nefs. The HIV-1 Vpu has adapted to specifically target human tetherin through direct interaction between their
respective transmembrane domains and mediates its TGN sequestration. Phosphorylation-dependent recruitment of a bTRCP2-SCF-Skp1 ubiquitin ligase
complex to Vpu induces ubiquitylation of the tetherin cytoplasmic tail and its subsequent degradation. The HIV-2 Env interacts with primate and human tetherins
through an undefined extracellular determinant and sequesters it in the TGN-dependent on an AP2-binding sorting signal in the gp41 cytoplasmic tail. Serra-
Moreno et al. show that in SIVmac DNef pathogenic revertant isolates, adaptive changes in Env gp41 cytoplasmic tail allow it to interact with rhesus tetherin
dependent on species-specific residues (PIL and RKM motifs) flanking its YDY sorting signal. Downregulation and sequestration of tetherin away from viral
assembly sites requires both an AP2-dependent sorting signal in Env and the AP1/2-dependent sorting signal in rhesus tetherin.
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countermeasures (Lim et al., 2010).
This study raises intriguing questions
about the role tetherin plays in SIV/HIV
pathogenesis and transmission. It is
unlikely that adaption to tetherin byDNefP
Env is itself the reason that this virus
reverted to pathogenicity. Many SIVs,
whose Nef proteins target tetherin, do
not cause progressive disease in their
natural hosts, and DNefP Env alone is
insufficient to restore pathogenicity to
parental SIVmacDNef (Alexander et al.,
2003). However, the potential growth
advantage that adapting Env gave to the
DNefP virus is likely to be an important
contributing factor. Importantly, these
data add significantly to the evidence
that HIVs and SIVs are under a strong
selective pressure to maintain a tetherin
countermeasure. Is this simply due to
tetherin inhibiting cell-free virion produc-
tion, or is there a further underlying
reason? Important questions to answer
now revolve around how widespread is4 Cell Host & Microbe 9, January 20, 2011 ª2HIV-2/SIV Env-mediated counteraction
of tetherin in infected individuals. HIV-2
infection displays a high incidence of
long-term nonprogression as well as
a limited geographical distribution (de
Silva et al., 2008). Does co-opting Env
for tetherin antagonism due to a lack of
Nef function (either through its deletion
or, as in HIV-2, the lack of a target
sequence in human tetherin) interfere
with its ‘‘normal’’ essential function in
virus replication? And can similar adap-
tions occur in the HIV-1 Env when Vpu
cannot counteract tetherin? Because
Vpu-mediated antagonism of human teth-
erin is efficient in the pandemic HIV-1
group M but weaker or nonexistent in
the nonpandemic groups N and O,
respectively, some speculate that Vpu
adaption to tetherin is associated with
efficient human-to-human spread (Sauter
et al., 2010). However, is there evidence of
Env adaption in HIV-1 groups N or O that
may compensate for lack of Vpu function?
One laboratory isolate of HIV-1 group M011 Elsevier Inc.(AD8) has been reported to have a Vpu-
like activity associated with Env (Schubert
et al., 1999). Whether this is a true tetherin
antagonist remains to be determined.
The interactions of primate immunode-
ficiency viruses with mammalian antiviral
factors, highlighted here by tetherin,
continue to provide fascinating insights
into the evolutionary fight for supremacy
between pathogen and host, with direct
relevance to human disease.
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Picornaviruses have evolved elaborate strategies to subvert host translation. In this issue of Cell Host and
Microbe, Ho et al. (2011) report that enterovirus infection induces the synthesis of a transcription factor
that enhances the synthesis of microRNA-141, which suppresses translation of the cap-binding protein,
eIF4E, mRNA to inhibit cap-dependent translation.Viruses are unable to carry the huge
amount of genetic information needed
to synthesize ribosomal proteins and
RNA. Thus, viruses have developed
numerous ways to compete for the host
translation machinery. All host mRNAs
contain 50 terminal cap structures. These
terminal cap structures bind the cap-
binding protein, eIF4E, which is part of
a larger complex, termed eIF4F, which
includes the RNA helicase eIF4A and
the multisubunit complex eIF4G (Fig-
ure 1A). The eIF4F complex is thought
to recruit the 40S ribosomal subunit to
the mRNA. The 40S subunit scans the
mRNA in a 50-to-30 direction until an
appropriate start codon is encountered,
at which point the 60S subunit joins and
polypeptide synthesis begins (Sonenberg
and Hinnebusch, 2009). Picornaviral
mRNAs, on the other hand, do not contain
50 cap structures. A large RNA structure
in the viral 50 noncoding region, termed
internal ribosome entry site (IRES),
recruits the 40S subunit. Consequently,
IRES-mediated association of 40S
subunits does not require eIF4E in most,
but not all, cases (Belsham and Sonen-
berg, 1996). To effectively compete
for host ribosomal subunits, picorna-
viruses employ several major strategies
(Figure 1A). (1) For example, poliovirusinfection induces the dephosphorylation
of eIF4E binding proteins (4E-BPs) that
sequester eIF4E, resulting in the inhibition
of cap-dependent translation (Gingras
et al., 1996). (2) Poliovirus-encoded
protease 2A cleaves eIF4G. The proteol-
ysis of eIF4G does not cause but
enhances the inhibition of cap-dependent
translation of host mRNAs (Gradi et al.,
1998). (3) Both poliovirus-encoded 2A
and 3C proteases cleave the polyadeno-
sine binding protein (PABP), leading to
reduced translation of both host and viral
mRNAs late in infected cells (Kuyumcu-
Martinez et al., 2004). (4) 2A and 3C prote-
ases cleave host transcription factors,
limiting newly transcribed mRNA species
that are preferentially translated (Yala-
manchili et al., 1997). Thus, it has been
assumed that picornavirus-induced cyto-
pathic effects can be explained by the
inhibition of transcription and translation
of host genes.
In this issue, Ho and colleagues
challenge this view by presenting the
remarkable finding that enterovirus 71
(EV71) infection results in the transcrip-
tional induction of the early growth
response 1 (EGR1) gene, a host transcrip-
tion factor. EGR1 protein activates the
transcription of a microRNA that re-
presses eIF4E mRNA translation, leadingto decreased abundance of eIF4E protein
(Figure 1B).
The study by Ho et al. started with
a straightforward question: Do microRNA
abundances change during EV71 infec-
tion of human rhabdomyosarcoma cells?
Because enterovirus infection inhibits
host-cell transcription, one would expect
downregulation of microRNAs or unal-
tered change in abundance of long-lived
microRNAs in infected cells. While 248
microRNAs followed that predicted
pattern, two microRNAs, miR-141 and
miR-146a, were upregulated more than
15-fold in EV71-infected cells compared
to uninfected cells (Ho et al., 2011).
Aided by target prediction programs
andverified in reporter-expressionassays,
the authors showed that miR-141 targets
eIF4E mRNA, leading to decreased
abundance of eIF4E. Sequestration of
miR-141 by anti-sense RNAs, so-called
antagomirs, effectively rescued eIF4E
protein abundance. This phenotype was
completely reversed by siRNA-mediated
depletion of eIF4E mRNA, suggesting
that miR-141 directly regulates eIF4E
mRNA expression (Ho et al., 2011). Inter-
estingly, treatment of infected cells with
miR-141 antagomir leads to a 1000-fold
decrease in virus production at a time
when eIF4G was completely cleaved9, January 20, 2011 ª2011 Elsevier Inc. 5
